EU Commission Notice C2020-9264 on Brexit

18.01.2021

On 22 December 2020, the EU Commission clarified with Notice C2020-9264 how to proceed with reference to Delegated Regulation EU 2016/161 on the safety features of pharmaceuticals in trade with the UK and Northern Ireland after Brexit.